Page 153 - EJMO-9-3
P. 153

Eurasian Journal of
            Medicine and Oncology                                                       CRCI factors in breast cancer



               doi: 10.3390/ijerph17238896                        of cancer therapy: Cognitive function (FACT-Cog) in breast
                                                                  cancer patients. J Clin Epidemiol. 2014;67(7):811-820.
            9.   Yao  S,  Zhang  Q,  Yao  X,  et al.  Advances  of  neuroimaging
               in  chemotherapy  related  cognitive  impairment  (CRCI)      doi: 10.1016/j.jclinepi.2014.01.010
               of patients with breast cancer.  Breast Cancer Res Treat.   19.  Xiao SY. Theoretical basis and research application of social
               2023;201:15-26.
                                                                  support rating scale. J Clin Psychiatry. 1994;4(2):98-100.
               doi: 10.1007/s10549-023-07005-y                 20.  Liu JY, Li FY, Lian YL. Investigation of reliability and
            10.  Regier NG, Naik AD, Mulligan EA,  et al. Cancer-related   validity of the social support scale.  J  Xinjiang  Med  Univ.
               cognitive impairment and associated factors in a sample of   2008;31(1):1-3.
               older male oral-digestive cancer survivors. Psychooncology.   21.  Boscher C, Joly F, Clarisse B,  et al. Perceived cognitive
               2019;28(7):1551-1558.                              impairment in breast cancer survivors and its relationships
               doi: 10.1002/pon.5131                              with psychological factors. Cancers (Basel). 2020;12(10):3000.
            11.  McHugh Power JE, Lawlor BA, Kee F. Social support      doi: 10.3390/cancers12103000
               mediates  the  relationships  between  extraversion,  22.  Abebe E, Tollesa T, Assefa M, et al. Cognitive functioning
               neuroticism, and cognitive function in older adults. Public   and its associated factors among breast cancer patients on
               Health. 2017;147:144-152.                          chemotherapy at Tikur Anbessa specialized hospital, Addis
               doi: 10.1016/j.puhe.2017.02.015                    Ababa  Ethiopia:  An  institution-based  comparative  cross-
                                                                  sectional study. BMC Cancer. 2021;21(1):1052.
            12.  Ibrahim EY, Domenicano I, Nyhan K, et al. Cognitive effects
               and depression associated with taxane-based chemotherapy      doi: 10.1186/s12885-021-08799-0
               in breast cancer survivors: A  meta-analysis.  Front Oncol.   23.  Gunstad J, Paul RH, Cohen RA, et al. Obesity is associated
               2021;11:642382.                                    with memory deficits in young and middle-aged adults. Eat
               doi: 10.3389/fonc.2021.642382                      Weight Disord. 2006;11(1):e15-e19.
            13.  Das A, Ranadive N, Kinra M, Nampoothiri M, Arora D,      doi: 10.1007/BF03327747
               Mudgal J. An overview on chemotherapy-induced cognitive   24.  Shefer G, Marcus Y, Stern N. Is obesity a brain disease?
               impairment and potential role of antidepressants.  Curr   Neurosci Biobehav Rev. 2013;37(10 Pt 2):2489-2503.
               Neuropharmacol. 2020;18(9):838-851.
                                                                  doi: 10.1016/j.neubiorev.2013.07.015
               doi: 10.2174/1570159X18666200221113842
                                                               25.  Lamport DJ, Chadwick HK, Dye L, et al. A low glycaemic load
            14.  Durán-Gómez N, López-Jurado CF, Nadal-Delgado  M,   breakfast can attenuate cognitive impairments observed in
               Pérez-Civantos D, Guerrero-Martín J, Cáceres MC.   middle aged obese females with impaired glucose tolerance.
               Chemotherapy-related cognitive impairment in patients   Nutr Metab Cardiovasc Dis. 2014;24(10):1128-1136.
               with breast cancer based on functional assessment and NIRS
               analysis. J Clin Med. 2022;11(9):2363.             doi: 10.1016/j.numecd.2014.04.015
               doi: 10.3390/jcm11092363                        26.  Kanaya AM, Barrett-Connor E, Gildengorin G, et al. Change
                                                                  in cognitive function by glucose tolerance status in older
            15.  Xu W, Wang K, Lian H. Linear convergence of decentralized   adults: A 4-year prospective study of the Rancho Bernardo
               estimation for statistical estimation using gradient method.   study cohort. Arch Intern Med. 2004;164(12):1327-1333.
               Neurocomputing. 2024;584:127584.
                                                                  doi: 10.1001/archinte.164.12.1327
               doi: 10.1016/j.neucom.2024.127584
                                                               27.  Awad N, Gagnon M, Messier C. The relationship between
            16.  Wagner L, Sweet JJ, Butt Z,  et al. Measuring patient self-  impaired glucose tolerance, type 2 diabetes, and cognitive
               reported cognitive function: Qualitative findings and initial   function. J Clin Exp Neuropsychol. 2004;26(8):1044-1080.
               development of the functional assessment of cancer therapy-
               cognitive function (FACT-Cog) instrument. J Support Oncol.      doi: 10.1080/13803390490517975
               2009;7(6):W32-W39.                              28.  Dye L, Boyle NB, Champ CL, Lawton CL. The relationship
            17.  Cheung YT, Si RL, Shwe M, et al. Psychometric properties   between obesity and cognitive health and decline. Proc Nutr
               and measurement equivalence of the English and Chinese   Soc. 2017;76(4):443-454.
               versions of the functional assessment of cancer therapy-     doi: 10.1017/S0029665117002014
               cognitive in Asian patients with breast cancer. Value Health.   29.  Kesler SR, Blayney DW. Neurotoxic effects of
               2013;16(6):1001-1013.
                                                                  anthracycline-  vs nonanthracycline-based chemotherapy
               doi: 10.1016/j.jval.2013.06.013                    on cognition in breast cancer survivors.  JAMA  Oncol.
                                                                  2016;2(2):185-192.
            18.  Cheung YT, Foo YL, Shwe M,  et al. Minimal clinically
               important difference (MCID) for the functional assessment      doi: 10.1001/jamaoncol.2015.4333


            Volume 9 Issue 3 (2025)                        145                         doi: 10.36922/EJMO025130073
   148   149   150   151   152   153   154   155   156   157   158